Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
- PMID: 15971272
- DOI: 10.1002/eji.200526090
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
Abstract
Lymphocyte activation gene 3 (LAG-3/CD223) is a CD4 homolog known to be selectively expressed in activated T and NK cells. It is thought to have a negative regulatory function in T cells. With the help of new monoclonal antibodies against mouse LAG-3, we show that LAG-3 surface expression is not limited to activated T and NK cells but is also found on activated B cells. Induction of B cell surface expression is T cell dependent and mediated by a soluble factor. The majority of LAG-3 on B cell surface is endogenously produced, even though soluble LAG-3 is present in the culture supernatants and can be passively absorbed. As B cells express LAG-3 in a T cell dependent manner and not when activated by Toll-like-receptor agonists alone, we propose LAG-3 as a new marker of T cell induced B cell activation.
Similar articles
-
Targeting Lymphocyte Activation Gene 3 to Reverse T-Lymphocyte Dysfunction and Improve Survival in Murine Polymicrobial Sepsis.J Infect Dis. 2020 Aug 17;222(6):1051-1061. doi: 10.1093/infdis/jiaa191. J Infect Dis. 2020. PMID: 32347939
-
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223).J Immunol. 2004 Dec 1;173(11):6806-12. doi: 10.4049/jimmunol.173.11.6806. J Immunol. 2004. PMID: 15557174
-
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.J Exp Med. 1992 Aug 1;176(2):327-37. doi: 10.1084/jem.176.2.327. J Exp Med. 1992. PMID: 1380059 Free PMC article.
-
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination.Trends Immunol. 2003 Dec;24(12):619-22. doi: 10.1016/j.it.2003.10.001. Trends Immunol. 2003. PMID: 14644131 Review.
-
The CD4-like molecule LAG-3, biology and therapeutic applications.Expert Opin Ther Targets. 2011 Jan;15(1):91-101. doi: 10.1517/14712598.2011.540563. Expert Opin Ther Targets. 2011. PMID: 21142803 Review.
Cited by
-
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade.J Nucl Med. 2021 Nov;62(11):1638-1644. doi: 10.2967/jnumed.120.258871. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712537 Free PMC article.
-
Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.Yonago Acta Med. 2015 Mar;58(1):39-44. Epub 2015 Mar 27. Yonago Acta Med. 2015. PMID: 26190896 Free PMC article.
-
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies.J Clin Med. 2020 Aug 6;9(8):2533. doi: 10.3390/jcm9082533. J Clin Med. 2020. PMID: 32781500 Free PMC article. Review.
-
LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors.Int J Mol Sci. 2022 Sep 1;23(17):9958. doi: 10.3390/ijms23179958. Int J Mol Sci. 2022. PMID: 36077354 Free PMC article. Review.
-
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.Int J Mol Sci. 2020 Oct 5;21(19):7357. doi: 10.3390/ijms21197357. Int J Mol Sci. 2020. PMID: 33027962 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
